Nordea Investment Management AB Increases Stock Position in DaVita Inc. $DVA

Nordea Investment Management AB lifted its holdings in shares of DaVita Inc. (NYSE:DVA) by 1.9% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 281,392 shares of the company’s stock after buying an additional 5,382 shares during the quarter. Nordea Investment Management AB owned about 0.37% of DaVita worth $39,673,000 at the end of the most recent quarter.

Other institutional investors also recently modified their holdings of the company. National Pension Service lifted its stake in shares of DaVita by 74.3% during the 1st quarter. National Pension Service now owns 197 shares of the company’s stock valued at $30,000 after buying an additional 84 shares in the last quarter. Y.D. More Investments Ltd bought a new stake in DaVita during the 1st quarter worth approximately $35,000. Ameritas Advisory Services LLC bought a new stake in DaVita during the 2nd quarter worth approximately $47,000. NewEdge Advisors LLC increased its holdings in DaVita by 20.8% during the 1st quarter. NewEdge Advisors LLC now owns 511 shares of the company’s stock worth $78,000 after acquiring an additional 88 shares during the period. Finally, University of Texas Texas AM Investment Management Co. bought a new stake in DaVita during the 1st quarter worth approximately $83,000. 90.12% of the stock is currently owned by hedge funds and other institutional investors.

Insider Activity

In other news, insider James O. Hearty sold 2,351 shares of the company’s stock in a transaction on Wednesday, July 23rd. The shares were sold at an average price of $150.00, for a total value of $352,650.00. Following the completion of the sale, the insider owned 26,038 shares of the company’s stock, valued at approximately $3,905,700. This represents a 8.28% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Company insiders own 1.50% of the company’s stock.

Analyst Upgrades and Downgrades

A number of analysts recently weighed in on the stock. Bank of America decreased their target price on shares of DaVita from $145.00 to $140.00 and set an “underperform” rating on the stock in a report on Wednesday, September 10th. Barclays decreased their target price on shares of DaVita from $160.00 to $149.00 and set an “equal weight” rating on the stock in a report on Thursday, October 9th. Wall Street Zen lowered shares of DaVita from a “buy” rating to a “hold” rating in a report on Saturday, October 11th. Truist Financial set a $140.00 target price on shares of DaVita in a report on Tuesday. Finally, Weiss Ratings reaffirmed a “hold (c+)” rating on shares of DaVita in a report on Wednesday, October 8th. Four research analysts have rated the stock with a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, the company has a consensus rating of “Reduce” and an average target price of $153.25.

DaVita Price Performance

Shares of NYSE:DVA opened at $125.79 on Friday. The company’s fifty day moving average price is $132.49 and its 200-day moving average price is $138.31. The firm has a market capitalization of $8.99 billion, a price-to-earnings ratio of 12.37, a PEG ratio of 0.90 and a beta of 1.13. DaVita Inc. has a one year low of $122.93 and a one year high of $179.60.

DaVita (NYSE:DVA) last announced its quarterly earnings data on Tuesday, August 5th. The company reported $2.95 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.70 by $0.25. DaVita had a net margin of 6.35% and a return on equity of 369.39%. The company had revenue of $3.38 billion during the quarter, compared to analysts’ expectations of $3.36 billion. During the same quarter in the prior year, the company earned $2.00 EPS. The firm’s revenue was up 6.1% on a year-over-year basis. DaVita has set its FY 2025 guidance at 10.200-11.300 EPS. As a group, equities research analysts expect that DaVita Inc. will post 10.76 EPS for the current year.

DaVita Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.